Skip to main content
ConductScienceScienceDex

Sophie Paczesny

From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.

FY2025 NIH rank #12,869
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8911469Search this ID in NIH RePORTER
ORCID iD
https://orcid.org/0000-0001-5571-2775Verified identifier for this researcher
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology

NIH Funding · FY2025

Linked Award Amount
$1.3M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#12,869
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Sophie Paczesny. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Sophie Paczesny as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA264921-04R01Contact PI
    Machine Learning to identify Biomarkers for Risk of Chronic Graft-Versus-Host Disease
    Medical University of South Carolina · Pharmacology (NIH department code)
    $693.9K
    award amount
  • 5R01HL158096-04R01Contact PI
    IL-33 induced-lL-9 producing type 2 innate lymphoid cells in the regulation of acute lung injury after hematopoietic stem cell transplantation (HSCT) in pediatric patients
    Medical University of South Carolina · Pharmacology (NIH department code)
    $562.6K
    award amount

Award organization

Organizations that administered FY2025 awards listing Sophie Paczesny as a PI.

FY2025 award administered by Medical University of South Carolina (SC).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Medical University of South Carolina
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    R01 Grant Holder
  6. 2026
    $5M Cumulative Funding
  7. 2026
    Entered Top 50% Nationally
    Ranked #5985

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Sophie Paczesny.

Brent R Logan
Medical University of South Carolina
3
shared awards
Amanda C. Larue
Medical University of South Carolina
1
shared award
Ashish A. Deshmukh
Medical University of South Carolina
1
shared award
Benjamin Andrew Toll
Medical University of South Carolina
1
shared award
Besim Ogretmen
Medical University of South Carolina
1
shared award
David T. Marshall
Medical University of South Carolina
1
shared award
Elizabeth G. Hill
Medical University of South Carolina
1
shared award
Jian Ouyang
Medical University of South Carolina
1
shared award
John J Lemasters
Medical University of South Carolina
1
shared award
John P O'Bryan
Medical University of South Carolina
1
shared award

Explore further

Find collaborators for Sophie Paczesny

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →